Alpine 4 Technologies, AzurRx Biopharma, and Eastgate Biotech Corp on CEO Money

Kent Wilson
CEO
Alpine 4 Technologies
www.alpine4.com

Alpine 4 Technologies (ALPP) continued its acquisition strategy in April with the announcement that it has completed its acquisition of American Precision Fabricators, Inc. (APF). This acquisition adds to Alpine 4’s tech manufacturing sector play, which began in 2016 with its purchase of Quality Circuit Assembly, Inc. It also is the fourth acquisition that Alpine 4 has made in two years.
Alpine 4 Technologies, Ltd (ALPP) is a publicly traded enterprise with business related endeavors in, Software, Automotive Technologies, Electronics Manufacturing, Energy Services & Fabrication Technologies and industries that support those market segments.

Thjis Spoor
President
AzurRx Biopharma – Nasdaq:AZRX
http://azurrx.com/
At AzurRx, we describe our company as “business led, science driven, and clinically advanced”— and at the forefront of developing therapies for digestive disorders. Since our beginning as a small research focused company, we have come a long way toward achieving our goal of being a fully integrated biotechnology company delivering the highest quality therapies possible to persons afflicted gastric impacted diseases. Our core technologies of next-generation enzymes are novel and advanced approaches to treating disease.

Mr. Spoor was previously President, Chief Executive Officer and a member of the board of directors of Fluoropharma Medical, Inc. from February 14, 2011 until December 31, 2015. Mr. Spoor was the CFO for Sunstone BioSciences, a nanotechnology firm and as a strategy consultant at Oliver Wyman working with biotechnology, pharmaceutical, medical device and health insurance companies. Mr. Spoor was an equity research analyst at J.P. Morgan and Credit Suisse covering the biotechnology and medical device industries.

Anna Gluskin
CEO
Eastgate Biotech Corporation
http://www.eastgatebiotech.com/

EastGate Biotech focuses on innovative technological developments and produces and distributes innovative drug compounds and healthy nutraceuticals that are based on natural therapies absorbed by the body. We utilize advanced nanotechnologies and alternative delivery systems that take difficult to deliver compounds and deliver them using our nanotechnology platform which ultimately increase the bioavailability to the body. Using our methods of delivery, provides healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain a healthy lifestyle. EastGate’s wholly owned subsidiary Omni Surgery and Anti-Aging Centre is the first of many surgery centers to come under the Omni umbrella as we plan to roll up existing business under the Omni brand and expand our footprint globally.